Acne isn’t just skin deep—it’s driven by complex cellular changes.
This study in #FASEBBioAdvances identifies key skin cell biomarkers linked to inflammation and potential new treatment targets: buff.ly/3WxMI72
🚨 Deadline today: Dec 31
Final chance to submit your work to Epigenetics in Human Disease in FASEB BioAdvances.
🔗 buff.ly/5pG7mcD
#LastCall #FASEBBioAdvances #OpenScience
From cancer to neurodegeneration, epigenetic changes play a major role in human disease.
Have research to share? Submissions are open for Epigenetics in Human Disease in FASEB BioAdvances.
⏰ Deadline: December 31
🔗 buff.ly/5pG7mcD
#Epigenomics #BiomedicalResearch #FASEBBioAdvances
Didn't confirm your hypothesis? Publish it anyway! Null results help move science forward. FASEB BioAdvances' Call for Papers is open through Dec 31, 2025.
Learn more: buff.ly/3ocvwtm
#Science #NullResults #FASEBBioAdvances
📣 Don’t miss new calls for papers! Get monthly alerts & deadlines via FASEB Pubs Monthly Newsletter!
👉 buff.ly/2wC9jnC
#FASEBJournal #FASEBBioAdvances #CallForPapers #SciencePublishing
🧪 Researchers tested whether MIB-626, a vitamin B3-derived supplement, could help COVID-19 patients with kidney injury by boosting NAD+—a vital molecule for immunity + cell repair.
🔗 Read more in #FASEBBioAdvances: buff.ly/eo6U02F
Iron supplements during pregnancy could help protect developing babies from damage caused by toxic metal exposure, including liver disease and poor growth, according to new research in #FASEBBioAdvances. 🤰
Read more: buff.ly/OIVmOGH
New research shows NPC1L1 contributes to osteoporosis by activating the C/EBPα–Cyp27a1–27-OHC pathway. Knockdown of NPC1L1 improved bone formation and reversed bone loss in mice. 🦴
Read the full study in #FASEBBioAdvances: buff.ly/Ezh7UTx
#Osteoporosis #NPC1L1 #BoneResearch
New study in #FASEBBioAdvances shows endurance exercise alters RNA splicing in skeletal muscle. Long-read sequencing reveals isoform-level changes that short-read data may miss. Read the full study: buff.ly/c73LNqA
#ExerciseScience #Splicing #RNA
A new study in FASEB BioAdvances finds that low COMMD10 levels in endothelial cells enhance angiogenesis and bone formation by activating the Rap1 pathway. This could inform future research in regeneration and bone repair.
📄 buff.ly/ST4nRgV
#FASEBBioAdvances #BoneResearch #Rap1
New research in FASEB BioAdvances shows the COVID-19 spike protein (S1) can enter brain cells through Neuropilin-1 and activate a cell death pathway. This may explain some neurological symptoms seen in COVID-19 patients.
📄 buff.ly/iye0gt1
#COVID19 #Neuroscience #FASEBBioAdvances
Top Read from #FASEBBioAdvances 🧠
New rat model mirrors the brain swelling & behavior seen in human hydrocephalus. It highlights key genes tied to inflammation—paving the way for better treatments.
Read the study: buff.ly/SoEcNZS
#Neuroscience
🔬 Top Read Research from 2024
Mice without a key cell cleanup system (CMA) still lose bone as they age. Surprising findings challenge what we thought about how bones age.
Read in #FASEBBioAdvances: buff.ly/75uO9ZB
#BoneHealth
Top Read Research from 2024 in #FASEBBioAdvances 🧬
Bitter taste receptors in skin cells? They help kickstart a detox response! Safe bitter compounds like saccharin activate ABCB1 to clear out toxins.
Learn more: buff.ly/ZbUyjAy
#SkinScience #TAS2Rs
New April Issue of #FASEBBioAdvances: How does global warming impact obesity? Plus research on blood pressure, kidney injury, gene recombination, and the integration of AI in precision medicine.
Read the latest findings:
Top Read Research from 2024: Fatty liver disease doesn't just affect the liver--it may damage the heart too. A study in #FASEBBioAdvances shows how fat buildup and fibrosis impair heart function in a mouse model of MASLD.
Read more: buff.ly/IpXpxvH
#HeartHealth #LiverDisease
Top Read Research from 2024: Microfluidics—tiny tech making a big impact in fertility. This sperm-sorting method boosts IVF/ICSI success by selecting high-quality sperm. Promising results in animals and potential in human ART.
🔗 buff.ly/Cj2tQt0
#FASEBBioAdvances
Top Read Research from 2024: Findings show how a key protein (TPP1) in lung cells helps fight damage from cigarette smoke. Without it, inflammation rises and disease risk grows. A possible new path for lung disease therapy. 🫁 🚬
🔗 buff.ly/965V8na
#LungResearch #TPP1 #FASEBBioAdvances
Top Read Research from 2024: How does gut health connect sleep apnea and heart disease? This review from #FASEBBioAdvances dives into what we know, and what's next for potential gut-targeted treatments. Learn more: buff.ly/Tz3mR3a
#GutMicrobiome #SleepScience #HeartHealth
📣 LAST DAY TODAY: FASEB BioAdvances Call for Papers on Epigenetics in Human Disease! Submit your research on epigenetic mechanisms in pathogenesis.
Learn more: buff.ly/phfebqT
#Epigenetics #FASEBBioAdvances
